Impact of quercetin in patients with myocardial infarction. A multicenter, randomized, and open-label pilot study.

Kozhukhov, Sergey; Parkhomenko, Alexander; Lutay, Yaroslav; Dovganych, Nataliia

Kozhukhov, Sergey; Parkhomenko, Alexander; Lutay, Yaroslav; Dovganych, Nataliia.

Affiliation

Kozhukhov S; Clinical Pharmacology Department, NSC "The M.D.Strazhesko Institute of Cardiology", Kyiv, Ukraine. Electronic address: s.kozhukhov@i.ua.
Parkhomenko A; Emergency Cardiology Department, NSC "The M.D.Strazhesko Institute of Cardiology", Kyiv, Ukraine. Electronic address: aparkhomenko@yahoo.com.
Lutay Y; Emergency Cardiology Department, NSC "The M.D.Strazhesko Institute of Cardiology", Kyiv, Ukraine. Electronic address: ylutay@i.ua.
Dovganych N; Clinical Pharmacology Department, NSC "The M.D.Strazhesko Institute of Cardiology", Kyiv, Ukraine. Electronic address: dovganychnat@gmail.com.

Hellenic J Cardiol ; 76: 68-74, 2024.

Article in En | MEDLINE | ID: mdl-37567562

Subject(s)
Key words

Cardioprotection; Infarct size; Myocardial infarction; Quercetin

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Percutaneous Coronary Intervention / ST Elevation Myocardial Infarction / Myocardial Infarction Type of study: Clinical_trials Limits: Humans Language: En Journal: Hellenic J Cardiol Journal subject: CARDIOLOGIA Year: 2024 Document type: Article Country of publication: Países Bajos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google